Tomorrow Can’t Wait: Every Canadian Deserves Access to Breakthrough Cancer Treatments

Tomorrow Can’t Wait: Every Canadian Deserves Access to Breakthrough Cancer Treatments OTTAWA, Feb. 04, 2022 (GLOBE NEWSWIRE) — Cancer ends more Canadian lives than anything else. In 2020, cancer killed 83,300 Canadians. New research from The Conference Board of Canada shows that although there are new breakthrough treatments available, many in Canada will not have access to … Continue reading Tomorrow Can’t Wait: Every Canadian Deserves Access to Breakthrough Cancer Treatments

WHAT THE OLYMPICS CAN TEACH THE “IKID” GENERATIONInspirational Advice From a Former Winter Olympic Hopeful & Award-Winning Author

WHAT THE OLYMPICS CAN TEACH THE “IKID” GENERATIONInspirational Advice From a Former Winter Olympic Hopeful & Award-Winning Author As a kid, Carew Papritz dreamed of being in the Winter Olympics. And being raised on cross-country skiing and racing, he knew this was his way in. When Carew was 17, he attended school in Norway for … Continue reading WHAT THE OLYMPICS CAN TEACH THE “IKID” GENERATIONInspirational Advice From a Former Winter Olympic Hopeful & Award-Winning Author

Rivalry Becomes One of the First Fully Registered Operators of Internet Gaming and Sports Betting in Ontario

Rivalry Becomes One of the First Fully Registered Operators of Internet Gaming and Sports Betting in Ontario TORONTO, Feb. 04, 2022 (GLOBE NEWSWIRE) — Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (FSE: 9VK) (OTCQX: RVLCF), an internationally-regulated sports betting and media company, today announced that it has become one of the first fully registered … Continue reading Rivalry Becomes One of the First Fully Registered Operators of Internet Gaming and Sports Betting in Ontario

Health Canada Authorizes TECENTRIQ® (atezolizumab) for Canadians with early non-small cell lung cancer (NSCLC)

In Canada, lung cancer is the most commonly diagnosed cancer, with estimates that 29,600 Canadians received a diagnosis in 20211 Tecentriq® (atezolizumab) is the first and only cancer immunotherapy approved for NSCLC in the adjuvant setting MISSISSAUGA, ON, Feb. 4, 2022 /CNW/ – Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on January 14, 2022, … Continue reading Health Canada Authorizes TECENTRIQ® (atezolizumab) for Canadians with early non-small cell lung cancer (NSCLC)

Fentanyl Deaths More Than Doubled in 30 States in Just Two Years 

Fentanyl Deaths More Than Doubled in 30 States in Just Two Years Fentanyl Deaths Among Teens Tripled, Deaths Among Black Teens Increased 5xNew Report: https://familiesagainstfentanyl.org/states/Akron, Ohio – In just two years, fentanyl poisoning deaths have doubled in the United States, and in 30 states, deaths have more than doubled according to a new analysis from Families Against Fentanyl. … Continue reading Fentanyl Deaths More Than Doubled in 30 States in Just Two Years